Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis

J Immunol. 2003 Aug 1;171(3):1556-63. doi: 10.4049/jimmunol.171.3.1556.

Abstract

The IL-7/IL-7R-dependent signaling pathway plays a crucial role in regulating the immune response in intestinal mucosa. Here we demonstrate the pivotal role of this pathway in the development and treatment of chronic colitis. T cells expressing high levels of IL-7R were substantially infiltrated in the chronic inflamed mucosa of TCR alpha-chain knockout mice and IL-7 transgenic mice. Transfer of mucosal T cells expressing high levels of IL-7R, but not T cells expressing low levels of IL-7R, from these mice into recombinase-activating gene-2(-/-) mice induced chronic colitis. Selective elimination of T cells expressing high levels of IL-7R by administrating small amounts of toxin-conjugated anti-IL-7R Ab completely ameliorated established, ongoing colitis. These findings provide evidence that therapeutic approaches targeting mucosal T cells expressing high levels of IL-7R are effective in the treatment of chronic intestinal inflammation and may be feasible for use in the therapy of human inflammatory bowel disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoptive Transfer
  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use
  • Cell Movement / genetics
  • Cell Movement / immunology
  • Chronic Disease
  • Colitis / genetics
  • Colitis / immunology*
  • Colitis / pathology
  • Colitis / therapy*
  • Disease Models, Animal
  • Genes, T-Cell Receptor alpha
  • Immunoconjugates / administration & dosage
  • Immunoconjugates / therapeutic use
  • Immunotoxins / administration & dosage
  • Immunotoxins / therapeutic use
  • Injections, Intraperitoneal
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / immunology*
  • Intestinal Mucosa / metabolism*
  • Intestinal Mucosa / transplantation
  • Lymphocyte Transfusion
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, SCID
  • N-Glycosyl Hydrolases / administration & dosage
  • N-Glycosyl Hydrolases / therapeutic use
  • Plant Proteins / administration & dosage
  • Plant Proteins / therapeutic use
  • Receptors, Interleukin-7 / biosynthesis*
  • Receptors, Interleukin-7 / immunology
  • Ribosome Inactivating Proteins, Type 1
  • Saporins
  • Severe Combined Immunodeficiency / genetics
  • Severe Combined Immunodeficiency / immunology
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism*
  • T-Lymphocyte Subsets / transplantation

Substances

  • Antibodies, Monoclonal
  • Immunoconjugates
  • Immunotoxins
  • Plant Proteins
  • Receptors, Interleukin-7
  • Ribosome Inactivating Proteins, Type 1
  • N-Glycosyl Hydrolases
  • Saporins